Global Lead Technical Product Specialist
at Cytiva
Dr. Klaus Hochleitner is cell and molecular biologist and is working on immuno- and molecular diagnostic applications for more than 30 years. He is presenting on lateral flow diagnostics and materials used therein at workshops and scientific conferences since 1997, and also holds a couple of patents in this field. His current role is Global Lead Technical Product Specialist Diagnostics for Cytiva.
Got a Question for Dr. Klaus Hochleitner?
Get in touch using the contact form linked here and we’ll get back to you shortly.
Lateral Flow Assays: The Rapid Rise in Molecular Diagnostics
Lateral Flow Assays: Optimizing Fiber Pads in Test Development and Manufacture
Join our webinar, hosted by Klaus Hochleitner, to take a detailed look at the raw materials, specified parameters and optimal uses for cellulose fiber and glass fiber pads in lateral flow tests.
In this webinar you will:
• Review the purposes of the different pads in lateral flow tests
• Understand the raw materials and specified parameters of cellulose fibers and glass fibers with special focus on thickness
• Review the guidelines for development and assay validation, including block-on-the-fly
• Determine the optimal uses for cellulose fiber and glass fiber pads
Lateral Flow Assays: Characterizing Antibodies Using SPR Technology
Lateral Flow Assays: Test Development, Optimization and Troubleshooting
Lateral Flow Assays: Discover the Importance of the Nitrocellulose Membrane
Join our webinar, hosted by Klaus Hochleitner, to take a deep dive into nitrocellulose membranes including the raw material, structure manufacturing process and capillary flow time and how these affect your lateral flow assays.
Klaus will also cover the effect of surfactants on protein binding and membrane properties and how to deal with unspecific binding of proteins to nitrocellulose membranes.
The Future of Diagnostics: Advancements, Challenges and Opportunities
In this webinar, our panel of industry experts will share insights on the molecular and immunodiagnostics market by looking at the external factors which will have the most significant impact in the next five years.
Our panel will also discuss the key challenges and opportunities facing the diagnostic industry and the developments that are likely to have the most impact on patients.